Cite
The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.
MLA
Gao, Fei, et al. “The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.” Diabetes Technology & Therapeutics, vol. 22, no. 4, Apr. 2020, pp. 256–64. EBSCOhost, https://doi.org/10.1089/dia.2019.0290.
APA
Gao, F., Ma, X., Peng, J., Lu, J., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., Jia, W., & Zhou, J. (2020). The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial. Diabetes Technology & Therapeutics, 22(4), 256–264. https://doi.org/10.1089/dia.2019.0290
Chicago
Gao, Fei, Xiaojing Ma, Jiahui Peng, Jingyi Lu, Wei Lu, Wei Zhu, Yuqian Bao, Robert A. Vigersky, Weiping Jia, and Jian Zhou. 2020. “The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.” Diabetes Technology & Therapeutics 22 (4): 256–64. doi:10.1089/dia.2019.0290.